Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004141127 | SCV003632269 | uncertain significance | not specified | 2022-10-26 | criteria provided, single submitter | clinical testing | The c.112G>A (p.V38M) alteration is located in exon 2 (coding exon 2) of the AXL gene. This alteration results from a G to A substitution at nucleotide position 112, causing the valine (V) at amino acid position 38 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |